Carl Dambkowski, Chief Medical Officer: Apogee Therapeutics APGE Sell · Filed 06/24

Trade details

Type: Insider sale
Amount: $3,500,640
Shares · price: 26,400 sh · $132.60 a share
Held after: 179,248 sh
Stock: Apogee Therapeutics APGE
Person: Carl DambkowskiChief Medical Officer
Trade date: 26/06/22
Filed: 26/06/24
Days to filing: 2 days

Sold 12.8% of holdings

Share of holding sold: 12.8%

Apogee Therapeutics trades, last 26 weeks

What else happened in Apogee Therapeutics around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Carl Dambkowski's recent trades

Carl DambkowskiDirector
Sell10b5-1 planOruka Therapeutics
Sell10b5-1 plan
Oruka Therapeutics
ORKA
$1.6M
22,417 sh
$1.6M
Filed 06/12
Traded 06/11
Carl DambkowskiDirector
Sell10b5-1 planOruka Therapeutics
Sell10b5-1 plan
Oruka Therapeutics
ORKA
$882.2K
12,583 sh
$882.2K
Filed 06/12
Traded 06/12
Carl DambkowskiDirector
Planned sale10b5-1 planOruka Therapeutics
Planned sale10b5-1 plan
Oruka Therapeutics
ORKA
$2.2M
35,000 sh
$2.2M
Filed 06/11
Traded 06/11
Carl DambkowskiChief Medical Officer
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$432.9K
5,500 sh
$432.9K
Filed 06/05
Traded 06/03
Carl DambkowskiDirector
Sell10b5-1 planOruka Therapeutics
Sell10b5-1 plan
Oruka Therapeutics
ORKA
$3.2M
53,447 sh
$3.2M
Filed 05/22
Traded 05/21